Thyroid, Fertility and Pregnancy: What Matters Before, During, and After

Untreated hypothyroidism reduces fertility and raises miscarriage risk. With levothyroxine dosed to a trimester-specific TSH target, pregnancy outcomes are normal. The dose typically rises 30 percent or more by 4 to 6 weeks of gestation, and TSH is checked every 4 weeks through the first half of pregnancy.

Why thyroid status matters for fertility

The thyroid axis sits upstream of the reproductive axis, so when it falters the effects ripple downward. Hypothyroidism — even subclinical — is associated with anovulatory cycles, luteal-phase defects, and elevated prolactin, all of which reduce the probability of conception [C1][C7]. The 2017 American Thyroid Association (ATA) pregnancy guideline summarizes this clearly: women with overt hypothyroidism have lower fertility rates, more menstrual disturbances, and higher miscarriage risk than euthyroid women [C1].

Two specific patterns are worth knowing [C1][C7]:

• Overt hypothyroidism (high TSH, low free T4) reduces fertility and significantly raises miscarriage, preterm birth, and gestational complication rates if left untreated.
• Thyroid autoimmunity (positive TPO antibodies) is independently associated with recurrent miscarriage and infertility even when TSH is in the normal range — a 2024 meta-analysis confirmed the link between anti-thyroid antibodies and recurrent pregnancy loss [C6].

A pregnant uterus also imposes new demands on the thyroid: hCG cross-stimulates the TSH receptor in early pregnancy, estrogen raises thyroxine-binding globulin, and the fetus depends entirely on maternal T4 for the first trimester before its own gland begins functioning around week 12 [C1][C8].

Pre-conception planning

The single highest-value thyroid intervention in fertility care happens before pregnancy, not during it. The ATA recommends that women with known hypothyroidism aim for a TSH below 2.5 mIU/L for at least a few months before trying to conceive [C1][C4].

Why 2.5 and not the general 4.0 upper limit? Because TSH naturally falls in the first trimester (driven by hCG), and patients whose preconception TSH was already on the higher end almost always need a dose increase as soon as pregnancy starts [C3][C4]. The Abalovich 2010 study showed that women with preconception TSH between 2.5 and 4.0 mIU/L required significantly more levothyroxine adjustments in early pregnancy than those whose TSH started below 1.2 [C4].

Practical pre-conception checks your endocrinologist will typically request [C1][C2][C8]:

• TSH to target below 2.5 mIU/L
• Free T4 to confirm replacement is adequate
• TPO antibodies at least once — positive antibodies raise miscarriage risk and change monitoring intensity [C6]
• Iron / ferritin, vitamin D, folate, B12 — all support both thyroid function and a healthy pregnancy
• Iodine status — sufficient but not excessive (the U.S. RDA in pregnancy is 220 mcg/day; megadosing is harmful) [C1][C8]

The pregnancy dose surge

Thyroid hormone demand rises sharply in early pregnancy. For a woman already on levothyroxine, T4 requirements increase by approximately 30 to 50 percent, and the change is detectable by 4 to 6 weeks of gestation [C1][C3][C4]. This is not gradual; it is a step change that the gland of a hypothyroid woman cannot meet on her existing dose.

The Yassa 2010 THERAPY trial tested a simple proactive strategy: as soon as a hypothyroid woman tests pregnant, she adds two extra levothyroxine doses per week (roughly a 29 percent increase). This approach successfully maintained TSH in the target range and prevented the first-trimester TSH spike that otherwise occurs [C3].

Your endocrinologist will typically [C1][C3][C8]:

• Increase the levothyroxine dose by approximately 25 to 30 percent the moment a pregnancy test turns positive (often by adding two extra weekly doses)
• Recheck TSH within 4 weeks
• Continue checking TSH every 4 weeks through roughly the first half of pregnancy
• Reduce monitoring frequency in the third trimester once the dose has stabilized

Trimester-specific TSH targets

The 2017 ATA guideline moved away from rigid universal cutoffs and now recommends population- and assay-specific reference ranges when available. When local ranges are not available, the commonly used trimester targets are [C1]:

• First trimester: approximately 0.1 to 2.5 mIU/L
• Second trimester: approximately 0.2 to 3.0 mIU/L
• Third trimester: approximately 0.3 to 3.0 mIU/L

These ranges reflect the natural decline in TSH driven by hCG and the gradual return toward baseline as pregnancy progresses [C1][C8]. Free T4 stays the most useful confirmation lab, though its interpretation in pregnancy requires a method-specific reference range.

Postpartum

Two things happen quickly after delivery [C1][C5]:

1. The dose drops back. Most women can return to their pre-pregnancy levothyroxine dose by 4 to 6 weeks postpartum, with a TSH check at 6 weeks to confirm [C1].
2. Postpartum thyroiditis becomes a real risk. Roughly 5 to 10 percent of women experience postpartum thyroiditis, an autoimmune inflammation that classically presents with a transient hyperthyroid phase (1 to 6 months postpartum) followed by a hypothyroid phase (3 to 12 months postpartum) [C1][C5]. TPO-positive women have a substantially higher risk [C5]. About one in five women with postpartum thyroiditis develop permanent hypothyroidism and need ongoing levothyroxine [C5].

Levothyroxine is compatible with breastfeeding — only trivial amounts enter breast milk, and adequate maternal thyroid hormone is essential for milk supply [C1][C8]. See our postpartum-thyroiditis article.

What does NOT help

Several heavily-marketed approaches lack evidence and can be harmful in pregnancy [C1][C2][C8]:

• Iodine megadosing. The pregnancy iodine requirement is 220 mcg/day. Doses well above this (kelp tablets, "thyroid support" blends with 1,000+ mcg iodine) can paradoxically suppress fetal thyroid function and worsen autoimmune thyroiditis [C1][C8].
• "Thyroid support" supplements. Blends containing bovine glandular thyroid, ashwagandha, or unspecified T3/T4 are not safe in pregnancy — they deliver unpredictable hormone amounts and are explicitly discouraged [C1][C2].
• Switching to T3-only or desiccated thyroid during pregnancy. The fetus depends on maternal T4 crossing the placenta. T3 does not cross effectively, so T3-only or T3-heavy regimens leave the fetus under-supplied. The ATA pregnancy guideline strongly recommends levothyroxine monotherapy throughout pregnancy [C1].
• Stopping levothyroxine to "let the thyroid recover." This is unsafe at any time and especially in early pregnancy, when fetal brain development depends on maternal T4 [C1].

Practical guidelines

1. Get TSH below 2.5 mIU/L before trying to conceive and confirm with your endocrinologist [C1][C4].
2. Check TPO antibodies at least once — positive antibodies change miscarriage risk and monitoring intensity [C1][C6].
3. Confirm adequate iron, vitamin D, folate, and iodine intake before conception [C1][C8].
4. Increase your levothyroxine dose the moment a pregnancy test is positive — your endocrinologist will typically add two extra weekly doses (roughly a 29 percent increase) [C3].
5. Monitor TSH every 4 weeks through the first half of pregnancy and as your endocrinologist directs after that [C1].
6. Drop back to your pre-pregnancy dose at 4 to 6 weeks postpartum with a TSH check at 6 weeks [C1].
7. Continue or restart breastfeeding without dose changes — levothyroxine is compatible [C1][C8].
8. Watch for postpartum thyroiditis symptoms in the first year, especially if TPO-positive — palpitations, weight loss, then fatigue and weight gain [C5].

Frequently asked questions

Do positive TPO antibodies cause miscarriage even with a normal TSH? Anti-thyroid antibodies are associated with a higher risk of recurrent miscarriage even when TSH is normal [C6]. Whether treating euthyroid TPO-positive women with low-dose levothyroxine prevents miscarriage is not fully settled in trials; the ATA does not universally recommend it but allows it on a case-by-case basis [C1][C6]. Discuss with your endocrinologist and obstetrician.

What if I have subclinical hypothyroidism (TSH high, T4 normal) in pregnancy? The ATA recommends treatment when TSH is above the trimester-specific upper limit, especially if TPO antibodies are positive. Treatment of subclinical hypothyroidism reduces some pregnancy complications [C1]. Your endocrinologist will decide based on TSH level, antibody status, and gestational age.

Is levothyroxine safe during breastfeeding? Yes. Only minimal amounts pass into breast milk, and adequate maternal thyroid hormone is needed for milk supply. The ATA explicitly supports breastfeeding on levothyroxine [C1][C8].

What is postpartum thyroiditis and how is it different from regular Hashimoto's? Postpartum thyroiditis is a transient autoimmune thyroid inflammation that affects 5 to 10 percent of women in the first year after delivery [C5]. It typically goes through a hyperthyroid phase, then a hypothyroid phase, and often resolves — though about 1 in 5 women progress to permanent hypothyroidism. It is more common in TPO-positive women [C1][C5].

Can I get pregnant naturally with Hashimoto's? Most women with Hashimoto's whose TSH is well-controlled (below 2.5 mIU/L) and who have addressed associated factors (iron, vitamin D, antibody status) conceive normally [C1][C7]. Persistent fertility difficulty beyond 6 to 12 months warrants a fertility workup that includes a thyroid review.

Bottom line

Hypothyroidism only threatens fertility and pregnancy when it is untreated, under-treated, or unmonitored [C1][C7]. With pre-conception TSH below 2.5 mIU/L, a 25 to 30 percent dose increase at the first positive pregnancy test, monitoring every 4 weeks through the first half of pregnancy, and trimester-appropriate TSH targets, outcomes match those of women without thyroid disease [C1][C3][C8]. Postpartum, the dose returns to baseline, and your endocrinologist will watch for postpartum thyroiditis in the first year — especially if TPO antibodies are positive [C1][C5]. Levothyroxine is compatible with breastfeeding [C1][C8].

Sources

1. [C1] Alexander EK et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315–389. PubMed: 28056690
2. [C2] Jonklaas J et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
3. [C3] Yassa L et al. Thyroid hormone early adjustment in pregnancy (the THERAPY trial). J Clin Endocrinol Metab. 2010;95(7):3234–3241. PubMed: 20463094
4. [C4] Abalovich M et al. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid. 2010;20(10):1175–1178. PubMed: 20860419
5. [C5] Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646–2655. PubMed: 12826640
6. [C6] Song H et al. Effect of anti-thyroid antibodies on recurrent miscarriage: A meta-analysis. 2024. PubMed: 38615687
7. [C7] Unuane D. Thyroid disorders and female infertility. 2026. PubMed: 41631700
8. [C8] American Thyroid Association. Hypothyroidism in Pregnancy — Patient Information. thyroid.org

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.